Pr0found Ventures

Portfolio of Ventures

The Largest and Most Expensive Health Condition & the Leading Cause of Preventable Death

Helping solve the student loan crisis by "rounding up" purchases to reduce debt by $22K & 13 years

Helping solve the student loan crisis by "rounding up" purchases to reduce debt by $22K & 13 years

image5

Bennufit™ Health, Inc. (“Bennufit™”)   operates a clinical analytics platform focused on solving the dueling health crises of chronic pain and opioid use disorder (OUD). The platform collects data and delivers reports to clinicians to improve outcomes. By assessing behavioral, lifestyle, environmental, demographic, genetic, wearable, medical device, and laboratory data, Bennufit™ delivers understandable and actionable information to better understand, diagnose, and treat the world’s most prevalent and expensive health condition – unresolved pain. 

Helping solve the student loan crisis by "rounding up" purchases to reduce debt by $22K & 13 years

Helping solve the student loan crisis by "rounding up" purchases to reduce debt by $22K & 13 years

Helping solve the student loan crisis by "rounding up" purchases to reduce debt by $22K & 13 years

image6

Zero Student Debt Initiative ("Zero")  is a proprietary, SaaS fintech platform that leverages the data and transactions from everyday purchases to make incremental payments towards student loans. By “rounding up” every purchase into a payment, and engaging contributions from employers, affiliated organizations, family, and friends, Zero’s proprietary fintech platform helps borrowers get to “zero” student loan debt faster by saving the average user $22,000 and 13 years off the life of their loans. Zero helps employers attract and retain educated employees, and universities engage their graduates. With a simple sign-up that takes less than 3 minutes, users begin saving instantly.  Backed by a university-affiliated venture fund which will close in April 2020

Preventing the Global Pandemic of Type 2 Diabetes through Telehealth and Digital Tools

Helping solve the student loan crisis by "rounding up" purchases to reduce debt by $22K & 13 years

Providing at-home rehab & data analysis for stroke recovery - 5th leading cause of death in the US

image7

Fruit Street Health ("Fruit Street") is the first Diabetes Prevention Program (DPP) provider to gain full recognition from U.S. Centers for Disease Control (CDC) that delivers the CDC diabetes prevention program via telemedicine and live video conferencing.  Partnering with Sharecare, Brigham and Women’s Hospital (BWH), Walgreens, and others, Fruit Street is 12-month weight loss program which has been designed for people who may be at risk for type 2 diabetes. Fruit Street has built a robust telehealth platform that allows for clinicians ranging from medical doctors to registered dieticians to deliver health and wellness services remotely. The platform is already integrated with FitBit and other devices to collect data. Fruit Street is backed by over 300 physicians who have invested over $17 million.

Providing at-home rehab & data analysis for stroke recovery - 5th leading cause of death in the US

Reduce the Poverty & Prison Pipeline by Delivering Evidence-Based Behavioral Health Coordinated Care

Providing at-home rehab & data analysis for stroke recovery - 5th leading cause of death in the US

image8

Flint Rehabilitation Devices ("FlintRehab") is an innovator in the at-home rehabilitation medical device and data analytics market. With two FDA-cleared devices , FlintRehab is helping patients recover from stroke - the 5th leading cause of death in America, as well as other neuro-degenerative conditions. FlintRehab spun out of UC Irvine.  Its technology includes the Music Glove, a hand therapy device that is clinically proven to improve hand function in 2 weeks, FitMi, the first home neurorehab device designed for recovery from head to toe, and MiGo platforms.  Backed by over $8 million in NIH-grant funding.

Reduce the Poverty & Prison Pipeline by Delivering Evidence-Based Behavioral Health Coordinated Care

Reduce the Poverty & Prison Pipeline by Delivering Evidence-Based Behavioral Health Coordinated Care

Reduce the Poverty & Prison Pipeline by Delivering Evidence-Based Behavioral Health Coordinated Care

image9

FidelityEHR ("Fidelity") brings together youth, families, educators, therapists and agencies on a "patient care centric" behavioral health technology platform to deliver clinically-proven improvements in health outcomes. Through evidence-based practices, care coordination, assessments driving the plan of care, and wraparound principles, Fidelity is the first care coordination health platform to undergo a  field-based randomized control trial to demonstrate its potential for positive impact on practitioner efficiency, job satisfaction, and efficiency. Initially funded through an NIH SBIR grant in collaboration with the University of Washington’s (UW) Department of Psychiatry and  Behavioral Sciences Wraparound Evaluation and Research Team (WERT). Backed by over $2M in angel funding so far and currently raising a new round.

Providing improved outcomes at the intersection of behavioral healthcare & advanced data technology

Reduce the Poverty & Prison Pipeline by Delivering Evidence-Based Behavioral Health Coordinated Care

Reduce the Poverty & Prison Pipeline by Delivering Evidence-Based Behavioral Health Coordinated Care

image10

IMCS Group ("IMCS") is the leader in biopsychosocial innovation for the workers’ compensation industry. IMCS has a proven transformative approach to injured workers based on evidence-based evaluation and treatment, its credentialed national network of over 1,000 psychologists and psychiatrists across all 50 states, and its technology platform that allows for tele-health and in-person interactions, outcomes analysis, and real-world evidence to expedite return-to-function and work. IMCS clients include many leading employers and workers compensation insurers, and the company is looking to expand into other payer categories.  Backed by CentriCap venture partners of Stamford, CT.

Rapidly Aging Population Which Will Account for 25% of the US Population in 15 Years

Growth of Neurological Disease Cost the U.S. more than $1.5 trillion per year—8.8% of GDP

Growth of Neurological Disease Cost the U.S. more than $1.5 trillion per year—8.8% of GDP

image11

BlueStar SeniorTech ("BSST") makes life better for senior veterans and their families by providing them with what they want: freedom, independence, dignity, and choice. BSST’s mission is to help American seniors age in the comfort of their homes:  safe, healthy, and connected. The company offers a combination of aging-at-home technologies and services to thousands of customers in all 50 states. BlueStar is veteran-owned, and it is certified by the Veterans Administration as a Service-Disabled Veteran-Owned Small Business (SDVOSB).  Backed by Driehaus Private Equity of Chicago.

Growth of Neurological Disease Cost the U.S. more than $1.5 trillion per year—8.8% of GDP

Growth of Neurological Disease Cost the U.S. more than $1.5 trillion per year—8.8% of GDP

Growth of Neurological Disease Cost the U.S. more than $1.5 trillion per year—8.8% of GDP

image12

The Brain Technology & Innovation Park ("Brain Park") is an ecosystem designed to support the commercialization of innovative device, diagnostic, digital, and therapeutic technologies discovered from the leading neuroscience researchers in the world belonging to the Society of Brain Mapping & Therapeutics (SBMT) and Brain Mapping Foundation.  The Brain Park initiative involves: (1) educational programs such as webinars to support new venture creation; an Entrepreneur-in-Residence program; a network of academic centers, investors, entrepreneurs, and service providers; and the annual World Congress of the SBMT. 

Pipeline of Challenges to Solve

STEALTH - The Increasing Failure of the Flu Vaccine to Protect Vulnerable Populations from the Flu

STEALTH - The Increasing Failure of the Flu Vaccine to Protect Vulnerable Populations from the Flu

STEALTH - The Increasing Failure of the Flu Vaccine to Protect Vulnerable Populations from the Flu

Working with Leading Microbiomic Researchers to Address the Failure of Flu Vaccines and the Epidemic of Flu Deaths in the Most Vulnerable Populations by Using Big Data

STEALTH - Poor Quality Outcomes Data in Healthcare to Determine Value and Evaluate Performance

STEALTH - The Increasing Failure of the Flu Vaccine to Protect Vulnerable Populations from the Flu

STEALTH - The Increasing Failure of the Flu Vaccine to Protect Vulnerable Populations from the Flu

Building the World’s Largest and Highest Quality Clinical Outcomes Database and Biobank to Address the Lack of Quality Outcomes Data in Clinical Practice Due to the Unreliability of EMR and Claims Data

STEALTH - Ability to Predict Health Risks for Senior Citizens and Track Outcomes

STEALTH - The Increasing Failure of the Flu Vaccine to Protect Vulnerable Populations from the Flu

STEALTH - Ability to Predict Health Risks for Senior Citizens and Track Outcomes

Building a longevity intelligence platform to deliver remote patient monitoring and chronic care that prevents episodes involving medical care or hospitalizations instead of waiting for the "I've fallen and I can't get up" alert following a tragic event.